28/06/2022
Collaborative works with researchers from AstraZeneca pharmaceutical company entitled «Population concentration-QTc modeling of anti-PCSK9 antisense oligonucleotide» (poster) and «Deciphering the mechanisms of drug effects on cardiovascular system through semi-mechanistic modeling of preclinical telemetry data: a validation study» (poster) were presented at the Meeting.
